SOD1 and amyotrophic lateral sclerosis: Sometimes, as in the case of the widely used SOD1 G93A transgenic model of ALS, this can be an advantage and a high protein level mediates the fast onset of phenotypes, enabling researchers to study disease trajectory; within ∼5 months these animals reach the humane endpoint.